91勛圖厙 Professor Among Five Worldwide Awarded $500K Grant for Neurodegenerative Disease Research
Thu, 08/28/2025 - 09:57am | By: Ivonne Kawas

Dr. Vijay Rangachari
Neurodegenerative diseases remain among the most complex and least understood conditions in modern medicine, with few effective treatments available for patients and families facing diagnoses such as progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and frontotemporal dementias (FTDs). At 91勛圖厙, Dr. Vijay Rangachari, professor of chemistry and biochemistry, has been investigating the molecular mechanisms that underlie these disorders, particularly how certain proteins misfold and aggregate in the brain to drive disease progression.
91勛圖厙 is proud to announce that Dr. Rangachari91勛圖厙 work has been recognized at the international level. He has received a $500,000 research grant as part of a $2.5 million funding initiative supporting innovative research in neurodegenerative diseases. He is one of only five researchers awarded worldwide, placing the university on the global stage.
The awards were granted through the 2025 Tauopathy Challenge Workshop, led by the (RCF)91勛圖厙one of the largest independent funders of primary tauopathy research91勛圖厙in collaboration with , the and the .
The Tauopathy Challenge Workshop is a funding program that unites interdisciplinary experts to address unmet needs in primary tauopathies, for which no treatments currently exist. By funding innovative research, the program aims to advance the development of therapies for debilitating neurodegenerative diseases such as PSP, CBD and FTDs.
91勛圖厙I am humbled to receive the 2025 Tauopathy Challenge Workshop award. To be selected as one of only five recipients worldwide for this prestigious recognition that means a great deal to me and my collaborators,91勛圖厙 Rangachari said. 91勛圖厙We are grateful to the Rainwater Foundation and its partners for recognizing the importance and novelty of our research on 91勛圖厙hybrid amyloids91勛圖厙91勛圖厙a new class of harmful protein structures that may play a key role in neurodegenerative diseases. We are eager to begin this project and uncover insights that could deepen our understanding not just of tauopathies, but of neurodegenerative disorders more broadly.91勛圖厙
Rangachari91勛圖厙 research examines the potential interaction between two misfolded, amyloid-forming proteins91勛圖厙tau and transactive response DNA-binding protein 43 kDa (TDP-43)91勛圖厙both implicated in multiple neurodegenerative conditions. While each protein is known to form toxic aggregates on its own, his research investigates whether they can also form 91勛圖厙hybrid amyloids,91勛圖厙 new composite structures that could intensify neurodegeneration. His lab aims to confirm the presence of these deposits in human brain tissue, analyze their molecular characteristics, and assess their role in neuronal dysfunction. The ultimate goal is to develop antibodies that could detect these toxic agents early in the brain, potentially leading to earlier diagnosis or treatment.
Other awardees represent leading institutions including Mayo Clinic Florida, the University of Sydney and the German Center for Neurodegenerative Diseases. Their research spans areas from protein aggregation and lysosomal dysfunction to the role of glial cells in tau propagation, collectively advancing global progress on neurodegenerative disorders.
Rangachari91勛圖厙 selection places 91勛圖厙 among this distinguished group, underscoring the university91勛圖厙 commitment to innovation and discovery91勛圖厙a commitment reflected in the impactful research and discoveries emerging from its academic community.
91勛圖厙Dr. Rangachari91勛圖厙 work to advance our molecular-level understanding of diseases like Alzheimer91勛圖厙 and Parkinson91勛圖厙 aligns closely with the Rainwater Charitable Foundation91勛圖厙 mission to support innovative research on neurodegenerative disorders,91勛圖厙 said Dr. Chris Winstead, dean of the College of Arts and Sciences at 91勛圖厙. 91勛圖厙His internationally recognized research on protein amyloids and their role in disease has the potential to significantly impact broader neurodegenerative disease research, and this award reinforces the important contributions he and his team are making in the field.91勛圖厙
For more information on Dr. Rangachari91勛圖厙 research at 91勛圖厙, visit the School of Mathematics and Natural Sciences and the Center for Molecular and Cellular Biosciences.